299 related articles for article (PubMed ID: 30665480)
21. Nail Involvement in Psoriatic Patients and Association with Onychomycosis: Results from a Cross-Sectional Study Performed in a Military Hospital in Tunisia.
Jendoubi F; Ben Lagha I; Rabhi F; Doss N; Mrabet A; Jaber K; Dhaoui MR
Skin Appendage Disord; 2019 Aug; 5(5):299-303. PubMed ID: 31559254
[TBL] [Abstract][Full Text] [Related]
22. Study of Nail Psoriasis and Dermoscopic Correlation with Dermoscopic and Modified Dermoscopic Nail Psoriasis Severity Indexes (dNAPSI and dmNAPSI).
Arora S; Paul D; Kumar R; Bhatnagar A; Arora G; Mech S; Suhag DK
Dermatol Pract Concept; 2022 Feb; 12(1):e2022010. PubMed ID: 35223155
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of systemic treatment agents on psoriatic nails: a comparative study.
Demirsoy EO; Kıran R; Salman S; Cağlayan C; Aktürk AS; Bayramgurler D; Bilen N
J Drugs Dermatol; 2013 Sep; 12(9):1039-43. PubMed ID: 24002153
[TBL] [Abstract][Full Text] [Related]
24. Dermoscopic Features of Psoriatic Nails and Their Correlation to Disease Severity.
Mashal ZR; Elgamal EEA; Zaky MS; Elsaie ML
Dermatol Res Pract; 2023; 2023():4653177. PubMed ID: 37223320
[TBL] [Abstract][Full Text] [Related]
25. The relationship between quality of life and the severity of psoriasis in Turkey.
Çakmur H; Derviş E
Eur J Dermatol; 2015 Apr; 25(2):169-76. PubMed ID: 25655046
[TBL] [Abstract][Full Text] [Related]
26. Extended report: nail disease in psoriatic arthritis--clinically important, potentially treatable and often overlooked.
Williamson L; Dalbeth N; Dockerty JL; Gee BC; Weatherall R; Wordsworth BP
Rheumatology (Oxford); 2004 Jun; 43(6):790-4. PubMed ID: 15113998
[TBL] [Abstract][Full Text] [Related]
27. Is the Nail Psoriasis Severity Index reliable in the assessment of nail psoriasis by rheumatologists?
Lubrano E; Scrivo R; Cantini F; Marchesoni A; Mathieu A; Olivieri I; Salvarani C; Scarpa R; Spadaro A
Arthritis Care Res (Hoboken); 2012 Mar; 64(3):455-8. PubMed ID: 22076786
[TBL] [Abstract][Full Text] [Related]
28. Psoriatic nail involvement and its relationship with distal interphalangeal joint disease.
Lai TL; Pang HT; Cheuk YY; Yip ML
Clin Rheumatol; 2016 Aug; 35(8):2031-2037. PubMed ID: 27251673
[TBL] [Abstract][Full Text] [Related]
29. The untold burden of isolated nail psoriasis: Delayed diagnosis and significant risk of psoriatic arthritis in a retrospective study at an academic center.
Chang MJ; Lee D; Desai AD; Lipner SR
J Am Acad Dermatol; 2023 May; 88(5):1192-1194. PubMed ID: 36621466
[No Abstract] [Full Text] [Related]
30. Comparison of NAPSI and N-NAIL for evaluation of fingernail psoriasis in patients with moderate-to-severe plaque psoriasis treated using ustekinumab.
Kim BR; Yang S; Choi CW; Youn SW
J Dermatolog Treat; 2019 Mar; 30(2):123-128. PubMed ID: 29757042
[TBL] [Abstract][Full Text] [Related]
31. Short-Term Correlation of the Psoriasis Area Severity Index, the Nail Psoriasis Area Severity Index, and the Dermatology Life Quality Index, before and after Treatment, in Patients with Skin and Nail Psoriasis.
Prevezas C; Katoulis AC; Papadavid E; Panagakis P; Rigopoulos D
Skin Appendage Disord; 2019 Nov; 5(6):344-349. PubMed ID: 31799260
[TBL] [Abstract][Full Text] [Related]
32. Factors associated with onychomycosis in nail psoriasis: a multicenter study in Pakistan.
Tabassum S; Rahman A; Awan S; Jabeen K; Farooqi J; Ahmed B; Masood S; Memon M; Rashid A; Soomro MR; Samdani AJ; Naveed S; Kapadia N
Int J Dermatol; 2019 Jun; 58(6):672-678. PubMed ID: 30615189
[TBL] [Abstract][Full Text] [Related]
33. Comparative Study of Clinical and Dermoscopic Features in Nail Psoriasis.
Wanniang N; Navya A; Pai V; Ghodge R
Indian Dermatol Online J; 2020; 11(1):35-40. PubMed ID: 32055506
[TBL] [Abstract][Full Text] [Related]
34. Ultrasonography of the nail unit reveals quantitative and qualitative alterations in patients with psoriasis and psoriatic arthritis.
Idolazzi L; Gisondi P; Fassio A; Viapiana O; Giollo A; Rossini M; Girolomoni G; Gatti D
Med Ultrason; 2018 May; 20(2):177-184. PubMed ID: 29730684
[TBL] [Abstract][Full Text] [Related]
35. Dermoscopic features of nail psoriasis treated with biologics.
Hashimoto Y; Uyama M; Takada Y; Yoshida K; Ishiko A
J Dermatol; 2017 May; 44(5):538-541. PubMed ID: 28150346
[TBL] [Abstract][Full Text] [Related]
36. The musculoskeletal impairment negatively impacts the quality of life of children and adolescents with psoriasis.
Meneghetti TC; Padilha TMH; Azevedo VF; Cat MNL; Sarolli BMS; de Carvalho VO
Adv Rheumatol; 2020 Jun; 60(1):33. PubMed ID: 32552795
[TBL] [Abstract][Full Text] [Related]
37. Scoring nail psoriasis.
Klaassen KM; van de Kerkhof PC; Bastiaens MT; Plusjé LG; Baran RL; Pasch MC
J Am Acad Dermatol; 2014 Jun; 70(6):1061-6. PubMed ID: 24698704
[TBL] [Abstract][Full Text] [Related]
38. Ustekinumab improves nail disease in patients with moderate-to-severe psoriasis: results from PHOENIX 1.
Rich P; Bourcier M; Sofen H; Fakharzadeh S; Wasfi Y; Wang Y; Kerkmann U; Ghislain PD; Poulin Y;
Br J Dermatol; 2014 Feb; 170(2):398-407. PubMed ID: 24117389
[TBL] [Abstract][Full Text] [Related]
39. Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial.
Elewski BE; Okun MM; Papp K; Baker CS; Crowley JJ; Guillet G; Sundaram M; Poulin Y; Gu Y; Geng Z; Williams DA; Rich PA
J Am Acad Dermatol; 2018 Jan; 78(1):90-99.e1. PubMed ID: 28993005
[TBL] [Abstract][Full Text] [Related]
40. Coexistence of onychomycosis in psoriatic nails: a descriptive study.
Natarajan V; Nath AK; Thappa DM; Singh R; Verma SK
Indian J Dermatol Venereol Leprol; 2010; 76(6):723. PubMed ID: 21079333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
